NCT06038747 is a NA clinical trial of Self-Monitoring in Psychotherapy, sponsored by University of North Carolina, Chapel Hill.

Who is sponsoring NCT06038747?

NCT06038747 is sponsored by University of North Carolina, Chapel Hill.

What drugs are being tested in NCT06038747?

Interventions in NCT06038747: Self-Monitoring, Individual Psychotherapy.

What condition does NCT06038747 study?

NCT06038747 studies Psychotherapy, Therapeutic Alliance, Psychological.

Is NCT06038747 still recruiting?

NCT06038747 is currently completed. Last updated 20 November 2024.

Last reviewed 2024-11-20 · How we verify

NCT06038747

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Self-monitoring and Reflection's Impact on Psychotherapy Outcomes: A Trial Protocol.

Completed NA Last updated 20 November 2024

What this trial tests

NA trial testing Self-Monitoring in Psychotherapy in 520 participants. Completed in 23 January 2024.

Timeline

15 September 2023

Primary endpoint
23 January 2024

23 January 2024

Quick facts

Lead sponsor	University of North Carolina, Chapel Hill
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	520
Start date	15 September 2023
Primary completion	23 January 2024
Estimated completion	23 January 2024
Sites	2 locations across United States

Drugs / interventions tested

Self-Monitoring
Individual Psychotherapy

Conditions studied

Psychotherapy — all drugs for Psychotherapy →
Therapeutic Alliance — all drugs for Therapeutic Alliance →
Psychological — all drugs for Psychological →

Sponsor

University of North Carolina, Chapel Hill

Who can join

Adults 18 to 99, any sex, with Psychotherapy or Therapeutic Alliance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this randomized controlled trial is to examine the influence of a brief post-session battery, designed to foster patient self-monitoring and reflection on their emotional reactions toward their psychotherapist, on the quality of the therapeutic relationship and treatment outcomes.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Enhancing Psychotherapy Outcomes by Encouraging Patients to Regularly Self-Monitor, Reflect on, and Share Their Affective Responses Toward Their Therapist: Protocol for a Randomized Controlled Trial.
Stefana A, Vieta E, Fusar-Poli P, Youngstrom EA. · · 2024 · cited 10× · PMID 38587881 · DOI 10.2196/55369
Effectiveness of a Novel Web-Based Intervention to Enhance Therapeutic Relationships and Treatment Outcomes in Adult Individual Psychotherapy: Randomized Controlled Trial and Analysis of Predictors of Dropouts.
Stefana A, Fusar-Poli P, Vieta E, Youngstrom EA. · · 2024 · PMID 39602203 · DOI 10.2196/63234

Verify or expand the search:

Other trials of Self-Monitoring

Trials testing the same drug.

NCT04675593 — Using mHealth to Improve Adherence and Reduce Blood Pressure in Individuals With Hypertension and Mood Disorders · NA · active not recruiting
NCT04633668 — Impact of Cognitive Behavioral Therapy on Parasomnias · NA · completed

Other recruiting trials for Psychotherapy

Currently open trials in the same condition.

NCT07147205 — Evaluation of Meaning-centered Group Psychotherapy in Integrative Medicine · NA · recruiting
NCT07010770 — SMART Therapist Training: A Hybrid Factorial-SMART Design · NA · recruiting
NCT06674499 — Development and Evaluation of a Self-Management Model for Cancer Rehabilitation · NA · active not recruiting
NCT04356924 — Psychological Treatment to Support the Consequences of Cognitive Impairment · NA · recruiting
NCT05587517 — A Clinical Trial of Interventions to Support Family Surrogates of Critically Ill Patients · Phase 2 · recruiting

Other University of North Carolina, Chapel Hill trials

Trials by the same sponsor.

NCT06841913 — Woodsmoke Exposure, Influenza Infection, and Nasal Immunity · Phase 4 · suspended
NCT07383428 — The INICIO-Guatemala Study · NA · not yet recruiting
NCT07528443 — Ultraprocessed Foods in Colombia · NA · not yet recruiting
NCT07507370 — CARED : A Novel Rapid Treatment Paradigm for Depression · NA · not yet recruiting
NCT07534254 — Piloting a Generative Artificial Intelligence Chatbot in a Mobile Weight Loss Program · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06038747 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of North Carolina, Chapel Hill
Last refreshed: 20 November 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06038747.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing